Logo image of PRPH

PROPHASE LABS INC (PRPH) Stock Price, Quote, News and Overview

NASDAQ:PRPH - Nasdaq - US74345W1080 - Common Stock - Currency: USD

0.3226  -0.03 (-7.3%)

PRPH Quote, Performance and Key Statistics

PROPHASE LABS INC

NASDAQ:PRPH (5/1/2025, 1:36:11 PM)

0.3226

-0.03 (-7.3%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High5.62
52 Week Low0.22
Market Cap13.51M
Shares41.88M
Float38.55M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-08 2025-05-08
IPO01-16 1984-01-16


PRPH short term performance overview.The bars show the price performance of PRPH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40 -60 -80

PRPH long term performance overview.The bars show the price performance of PRPH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PRPH is 0.3226 USD. In the past month the price decreased by -13.86%. In the past year, price decreased by -93.58%.

PROPHASE LABS INC / PRPH Daily stock chart

PRPH Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 62.44 769.45B
JNJ JOHNSON & JOHNSON 15.43 373.60B
NVO NOVO-NORDISK A/S-SPONS ADR 18.99 291.73B
NVS NOVARTIS AG-SPONSORED ADR 13.22 220.14B
AZN ASTRAZENECA PLC-SPONS ADR 18.94 218.45B
MRK MERCK & CO. INC. 10.73 210.36B
PFE PFIZER INC 7.5 136.51B
SNY SANOFI-ADR 14.09 133.13B
BMY BRISTOL-MYERS SQUIBB CO 6.77 101.17B
GSK GSK PLC-SPON ADR 7.1 79.12B
ZTS ZOETIS INC 26.43 69.78B
TAK TAKEDA PHARMACEUTIC-SP ADR 32.75 47.41B

About PRPH

Company Profile

PRPH logo image ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. The company is headquartered in New York City, New York and currently employs 96 full-time employees. The firm provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.

Company Info

PROPHASE LABS INC

711 Stewart Ave, Suite 200, Garden City

New York City NEW YORK 11530 US

CEO: Ted Karkus

Employees: 113

Company Website: https://www.prophaselabs.com/

Investor Relations: http://www.prophaselabs.com/investors/annual-reports/

Phone: 12153450919

PROPHASE LABS INC / PRPH FAQ

What is the stock price of PROPHASE LABS INC today?

The current stock price of PRPH is 0.3226 USD. The price decreased by -7.3% in the last trading session.


What is the ticker symbol for PROPHASE LABS INC stock?

The exchange symbol of PROPHASE LABS INC is PRPH and it is listed on the Nasdaq exchange.


On which exchange is PRPH stock listed?

PRPH stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for PROPHASE LABS INC stock?

7 analysts have analysed PRPH and the average price target is 16.32 USD. This implies a price increase of 4958.9% is expected in the next year compared to the current price of 0.3226. Check the PROPHASE LABS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PROPHASE LABS INC worth?

PROPHASE LABS INC (PRPH) has a market capitalization of 13.51M USD. This makes PRPH a Nano Cap stock.


How many employees does PROPHASE LABS INC have?

PROPHASE LABS INC (PRPH) currently has 113 employees.


What are the support and resistance levels for PROPHASE LABS INC (PRPH) stock?

PROPHASE LABS INC (PRPH) has a support level at 0.24 and a resistance level at 0.35. Check the full technical report for a detailed analysis of PRPH support and resistance levels.


Is PROPHASE LABS INC (PRPH) expected to grow?

The Revenue of PROPHASE LABS INC (PRPH) is expected to grow by 64.06% in the next year. Check the estimates tab for more information on the PRPH EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PROPHASE LABS INC (PRPH) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PROPHASE LABS INC (PRPH) stock pay dividends?

PRPH does not pay a dividend.


When does PROPHASE LABS INC (PRPH) report earnings?

PROPHASE LABS INC (PRPH) will report earnings on 2025-05-08.


What is the Price/Earnings (PE) ratio of PROPHASE LABS INC (PRPH)?

PROPHASE LABS INC (PRPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.34).


What is the Short Interest ratio of PROPHASE LABS INC (PRPH) stock?

The outstanding short interest for PROPHASE LABS INC (PRPH) is 3.31% of its float. Check the ownership tab for more information on the PRPH short interest.


PRPH Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PRPH Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PRPH. Both the profitability and financial health of PRPH have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRPH Financial Highlights

Over the last trailing twelve months PRPH reported a non-GAAP Earnings per Share(EPS) of -2.34. The EPS decreased by -138.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -30.23%
ROE -72.8%
Debt/Equity 0.29
Chartmill High Growth Momentum
EPS Q2Q%-211.76%
Sales Q2Q%-157.09%
EPS 1Y (TTM)-138.78%
Revenue 1Y (TTM)-80.65%

PRPH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to PRPH. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 75.59% and a revenue growth 64.06% for PRPH


Ownership
Inst Owners8.33%
Ins Owners11.16%
Short Float %3.31%
Short Ratio0.14
Analysts
Analysts82.86
Price Target16.32 (4958.9%)
EPS Next Y75.59%
Revenue Next Year64.06%